Navigation Links
China Biologic Reports Financial Results for the Second Quarter of 2014
Date:8/5/2014

er 31, 2013. Restricted deposits were $102.1 million as of June 30, 2014, compared to $30.5 as of December 31, 2013. The increase was primarily due to a deposit of $72.3 million as cash collateral for certain long-term bank loans in connection with a payment of $70.0 million for share repurchase. Net cash provided by operating activities for the six months ended June 30, 2014 was $39.0 million, as compared to $37.9 million for the six months ended June 30, 2013. The increase in net cash provided by operating activities was primarily due to the increase in net income for the six months ended June 30, 2014 as compared to the same period in 2013, partially offset by the increase of accounts receivable and the inventories during this period. Accounts receivable increased by $7.5 million, in line with the sales increase during the six months ended June 30, 2014, as compared to $6.3 million during the same period in 2013. Inventories increased by $6.9 million during the six months ended June 30, 2014, as compared to $3.6 million during the same period in 2013. This increase was primarily due to an increase in raw materials as a result of the continued supply of plasma, a primary raw material, by plasma stations of Guizhou Taibang while its production of plasma products had been suspended from June 2013 to March 2014.

OutlookFor the full year of 2014, the Company reiterates its full year financial forecast of total sales in the range of $230 million to $240 million and full year non-GAAP adjusted net income in the range of $67 million to $69 million. This guidance assumes only organic growth and excludes acquisitions and necessarily assumes no significant adverse product price changes during 2014.

This forecast reflects the Company's current and preliminary views, which are subject to change.

Conference CallThe Company will host a conference call at 8:00 am, Eastern Time on Wednesday, August 6, 2014, which is 8:00 pm, Beijing Time
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. China Ureteroscopes Market Outlook to 2020
2. Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care
3. China Nepstar Chain Drugstore to Report Second Quarter 2014 Financial Results on August 28, 2014
4. China Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
5. Global & China Market: Glucosamine, Coenzyme Q10 & Cysteine Methyl Ester
6. Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions
7. Decision Resources Group Announces First Medical Device Account Targeting Tool in China
8. Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China
9. The Global and China Insulin Market is Expected to Grow at a CAGR of 6.1% From 2013 to 2019 to Reach USD 32.24 Billion in 2019
10. China Biologic to Report Second Quarter 2014 Financial Results
11. CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... and TORONTO , Aug. 27, 2015 ... today announced the issuance of a white paper on ... insulin spray product.  The white paper was presented to ... stockholders by Dr. James H. Anderson, Jr. , ... may be viewed online on the Generex website. ...
(Date:8/27/2015)... pharmaceutical and medical device companies and leading law firms will ... on Oct. 20, discussing issues surrounding regulatory compliance, ... Litigation Conferences has announced. To learn more ... The program is co-chaired by Megan Grossman ... Hart Yeary of Dechert LLP. Topics include: ...
(Date:8/27/2015)... -- Mytrus, a technology and services company revolutionizing clinical trials, announced today ... received approval for use by Britain,s ... time e-Consent technology will be used in a trial ... Mytrus was also the first electronic informed consent technology ... U.S. Food and Drug Administration in 2011. It has ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
... U L URUI nc. (NYSE Amex: ... an abbreviated 510(k) application with the U.S. Food and Drug ... and mitigation of pain. The principal data supporting ... to Acquacel® Ag in skin graft donor sites. This amended ...
... 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... "Company"), a leading China-based pharmaceutical and biotechnology ... that its wholly-owned contract research subsidiary, Shanghai ... agreement with Shenogen Pharma Group to develop ...
Cached Medicine Technology:ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group 2
(Date:8/27/2015)... ... 2015 , ... Keck Graduate Institute (KGI), School of Pharmacy celebrated its Second ... formal ceremony recognizing them as members of the 2nd class of the KGI School ... dedication to clinical service and patient care, the White Coat Ceremony is held every ...
(Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of 10 ... and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to assist ... a $7,500 scholarship to assist in his goal of becoming a foreign diplomat with ...
(Date:8/27/2015)... ... August 27, 2015 , ... According to ... treat a patient with hemophilia is $175,000. Hemophilia is an inherited, life-long condition ... treatment. The RMHBDA exists to help raise funds for patients suffering from bleeding ...
(Date:8/27/2015)... Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... most recent World Conference on Abdominal Wall Hernia Surgery involved many conversations between hernia ... mesh options out there, the article notes that many different experts have different ideas ...
(Date:8/27/2015)... ... , ... In an article published July 30th by the New ... Orleans, highlighting a security firm that is tasked with providing supplemental protection. Called the ... worked with the city to provide private security when it is needed in a ...
Breaking Medicine News(10 mins):Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2
... among people exposed to toxic gases from the Union Carbide ... the Bhopal gas tragedy Sunday demanded free treatment of the ... government. ,The Bhopal tragedy occurred on the night ... methyl iso-cyanate (MIC) spewed out of the pesticide plant, in ...
... serious and progressive medical condition, has been and remains ... for kidney function, people who are at high risk ... those at increased risk for potentially undiagnosed CKD, a ... Cornell Medical College and the University of North Carolina ...
... with the involvement of social services in the case of Connor ... three times the average for his age. ,The boy ... not undergo a sea change. He holds a record of breaking ... ,Connor’s mother and grandmother are expected to attend a child ...
... most common treatments for prostate cancer - may increase the ... 65, according to a new study. ,The study ... of men with prostate cancer. Although the findings need to ... oncologists should weigh the benefits of androgen deprivation therapy, or ...
... the HIV case in Libya involving five Bulgarian nurses and ... claimed that they were tortured brutally to give false testimonies. ... 1999 when they were accused of starting an HIV epidemic ... scientists, the infections have begun much before the arrival of ...
... the black soya bean-preventing// diabetes. ,The scientists from ... study in the Journal of Agricultural Food and Chemistry and ... when included in a daily diet can help prevent sugar ... soya hindering weight gain and lowering the levels of ...
Cached Medicine News:Health News:Bhopal Gas Victims Demand Treatment of Children With Birth Defects 2Health News:Simple Model to Predict Chronic Kidney Disease 2Health News:Simple Model to Predict Chronic Kidney Disease 3Health News:Grossly Overweight Boy Likely to Be Sent into Care 2Health News:Prostate Cancer Therapy may Increase Risk of Death in Older Patients 2
... The use of guaiac as a test ... the oxidation of phenolic compounds present in guaiac ... blue color. If blood is present, the heme ... a pseudoenzymatic manner, catalyzing the release of oxygen ...
... The Original MaybeMom™ Mini Ovulation ... diagnostic instument which uses a ... personal menstrual/fertility cycle, including key ... and menstruation to increase her ...
... only test designed specifically for detecting ... pH. It includes a convenient pH ... range which is important in monitoring ... can now spend less time testing ...
... FSH Menopause Predictor Test is a ... detection of Follicle Stimulating Hormone (FSH) ... body hormone changes related to the ... menopause. The FHS Menopause Predictor ...
Medicine Products: